September 1, 2022
Via: Biopharma DiveThe approval comes after more than two decades of research and development by rare disease specialist Genzyme, which Sanofi bought in 2011 for $20.1 billion. Patients with ASMD suffer from a lack of an enzyme needed to break down a […]
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 1, 2023
September 14, 2023
September 20, 2023
August 30, 2023